Vivos is a late stage radiation oncology focused medical device company engaged in the development of yttrium-90 based brachytherapy devices for the treatment of non resectable tumors. The Company is engaged in the development of RadioGel, an Yttrium-90 based brachytherapy device, for the treatment of tumors.
|Employees (est.) (Feb 2019)||2||(-50%)|
|Share Price (Oct 2017)||$0.1||(-19%)|
Market capitalization (8-Oct-2018)
Vivos has 1.1k Twitter Followers. The number of followers has decreased 0.5% month over month and decreased 0.4% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Vivos founded?
Vivos was founded in 2006.
Who are Vivos key executives?
Vivos's key executives are Michael Pollack, Carlton Cadwell and Mike Korenko.
How many employees does Vivos have?
Vivos has 2 employees.
Who are Vivos competitors?
Competitors of Vivos include PhaseBio Pharmaceuticals, Charles River Laboratories International and OptiNose.
Where is Vivos headquarters?
Vivos headquarters is located at 719 Jadwin Ave, Richland.
Where are Vivos offices?
Vivos has an office in Richland.
How many offices does Vivos have?
Vivos has 1 office.
Receive alerts for 300+ data fields across thousands of companies